New York S 6045: Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry

Status: REFERRED TO HEALTH (as of 2022-01-05)

State: New York · Session: 2021-2022 · Bill: S 6045

Sponsors: HARCKHAM

View New York S 6045 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.